India’s biotechnology sector has achieved a significant milestone, currently valued at $150 billion. Despite this impressive figure, much of the sector's innovation and product development potential remains untapped. Jitendra Kumar, Managing Director of the Biotechnology Industry Research Assistance Council (BIRAC), underscored the necessity for increased
Since July 2023 only 14 serious international complaints received , being future ready for coming winter season more than 8000 batches of cough syrup tested and only 2-3 per cent failures found The Central Drugs Standard Control Organization (CDSCO) announced a low failure rate of just
Pune based, Serigen Mediproducts, a unique biomedical products manufacturing company has raised INR 10 crores from IAN Alpha Fund & Colossa Ventures, along with existing and new angel investors. This significant financial boost will be instrumental in furthering the company’s mission to revolutionize regenerative medicine.
The Three day International Exhibition For Pharma And Healthcare Exhibition (IPHEX 2024) begins More than 400 Major Indian pharma companies to showcase their pharmaceutical products and Technologies at the expo More than 400 foreign buyers from across the world to attend .India exported pharma products worth
Bangalore-based biotechnology company, Cambrian Bioworks has secured $1.45 million in seed funding. The company builds cutting-edge solutions for the rapidly expanding next-generation sequencing (NGS) and molecular diagnostic markets. The round was spearheaded by the Irani family office, which has invested in several private ventures across
Dr Shivani Sharma, Vice-President of Pathology Services and Lab Director India is experiencing a significant change in healthcare towards personalized and precision medicine due to the advancements in molecular testing technologies. This change is leading to new possibilities in disease diagnosis, treatment selection, and patient care.
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market. (TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
The Atal Incubation Centre - Centre for Cellular and Molecular Biology (AIC-CCMB), a premier bio-incubator in Hyderabad, has signed an agreement with Thermo Fisher Scientific. The agreement includes equipping AIC-CCMB’s state-of-the-art facility, the Centre for Innovation, with cutting-edge technology to enable scientists in start-ups with
In a significant stride towards enhancing global health security and pandemic preparedness, TechInvention Lifecare Pvt. Ltd. is proud to announce the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with an investment of approx. USD 15 million. The centre is strategically located
The new technology “Nano Hydroxyapatite-Based Porous Polymer Composite Scaffolds for Bioactive Molecule Delivery in Musculoskeletal Regeneration” has been indigenously developed through original research by Prof. Ashok Kumar and his team from the Department of Biological Sciences & Bioengineering, IIT Kanpur The Indian Institute of Technology
